Sutro Biopharma (STRO) Short Interest Ratio & Short Volume → Man who spotted Apple at $1.49 says: “Buy These 6 AI Stocks.” (From InvestorPlace) (Ad) Free STRO Stock Alerts $4.01 -0.14 (-3.37%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Sutro Biopharma Short Interest DataCurrent Short Volume1,950,000 sharesPrevious Short Volume2,180,000 sharesChange Vs. Previous Month-10.55%Dollar Volume Sold Short$6.62 millionShort Interest Ratio / Days to Cover2.0Last Record DateApril 30, 2024Outstanding Shares81,790,000 sharesPercentage of Shares Shorted2.38%Today's Trading Volume388,410 sharesAverage Trading Volume616,897 sharesToday's Volume Vs. Average63% Short Selling Sutro Biopharma ? Sign up to receive the latest short interest report for Sutro Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSTRO Short Interest Over TimeSTRO Days to Cover Over TimeSTRO Percentage of Float Shorted Over Time Ad True Market InsidersThe CHIPS Act MotherlodeIf you haven’t heard yet, the CHIPS Act is the US government pouring $280 BILLION into the manufacturing of US semiconductors. A lot of companies will make a fortune from this.Click here to see my #1 investment for 2024. Sutro Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,950,000 shares $6.62 million -10.6%N/A2 $3.40 4/15/20242,180,000 shares $9.03 million -9.5%N/A2.2 $4.14 3/31/20242,410,000 shares $13.62 million +3.9%N/A2.3 $5.65 3/15/20242,320,000 shares $9.54 million -3.7%N/A2.6 $4.11 2/29/20242,410,000 shares $11.83 million -9.7%N/A2.9 $4.91 2/15/20242,670,000 shares $11.99 million +2.3%N/A3.2 $4.49 Get the Latest News and Ratings for STRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sutro Biopharma and its competitors with MarketBeat's FREE daily newsletter. 1/31/20242,610,000 shares $11.33 million +8.8%N/A2.9 $4.34 1/15/20242,400,000 shares $9.60 million +1.7%N/A2.7 $4.00 12/31/20232,360,000 shares $10.12 million +24.2%N/A2.6 $4.29 12/15/20231,900,000 shares $7.56 million -8.2%N/A2.4 $3.98 11/30/20232,070,000 shares $5.40 million -10.0%N/A3 $2.61 11/15/20232,300,000 shares $5.66 million -3.0%N/A3.7 $2.46 10/31/20232,370,000 shares $6.52 million -4.4%N/A5.3 $2.75 10/15/20232,480,000 shares $9.77 million +5.1%N/A6.2 $3.94 9/30/20232,360,000 shares $8.19 million -2.5%N/A6.3 $3.47 9/15/20232,420,000 shares $9.46 million +28.7%N/A7.9 $3.91 8/31/20231,880,000 shares $8.93 million -2.1%N/A4.5 $4.75 8/15/20231,920,000 shares $8.20 million -1.5%N/A4.5 $4.27 7/31/20231,950,000 shares $8.72 million -1.5%N/A4.3 $4.47 7/15/20231,980,000 shares $9.37 million +2.1%N/A4 $4.73 6/30/20231,940,000 shares $9.02 million -36.8%N/A3.8 $4.65 6/15/20233,070,000 shares $16.61 million +2.0%N/A5.6 $5.41 5/31/20233,010,000 shares $13.51 million -2.9%N/A6.2 $4.49 5/15/20233,100,000 shares $18.23 million +4.4%N/A6.6 $5.88 4/30/20232,970,000 shares $12.65 million -2.3%N/A6.5 $4.26 4/15/20233,040,000 shares $13.38 million +8.6%N/A7.1 $4.40 3/31/20232,800,000 shares $12.94 million +77.2%N/A5.5 $4.62 3/15/20231,580,000 shares $8.53 million -16.0%N/A2.9 $5.40 2/28/20231,880,000 shares $10.60 million +0.5%N/A3.3 $5.64 2/15/20231,870,000 shares $11.61 million -3.6%N/A3.3 $6.21 1/31/20231,940,000 shares $14.05 million -8.1%N/A3.4 $7.24 1/15/20232,110,000 shares $16.61 million +8.2%N/A3.6 $7.87 12/30/20221,950,000 shares $15.76 million -22.9%N/A3.7 $8.08 12/15/20222,530,000 shares $18.60 million -4.2%N/A5.3 $7.35 11/30/20222,640,000 shares $19.77 million -30.7%N/A6.9 $7.49 11/15/20223,810,000 shares $27.93 million -8.2%N/A10.7 $7.33 10/31/20224,150,000 shares $30.42 million +0.2%9.2%12.6 $7.33 10/15/20224,140,000 shares $23.14 million +2.7%9.2%11.3 $5.59 9/30/20224,030,000 shares $22.37 million -5.0%8.9%11.3 $5.55 9/15/20224,240,000 shares $24.34 million -11.3%9.4%5.8 $5.74Forget Bitcoin: This $8 Stock Is the Next Big Thing (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> STRO Short Interest - Frequently Asked Questions What is Sutro Biopharma's current short interest? Short interest is the volume of Sutro Biopharma shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 1,950,000 shares of STRO short. Learn More on Sutro Biopharma's current short interest. What is a good short interest ratio for Sutro Biopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. STRO shares currently have a short interest ratio of 2.0. Learn More on Sutro Biopharma's short interest ratio. Is Sutro Biopharma's short interest increasing or decreasing? Sutro Biopharma saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 1,950,000 shares, a decrease of 10.6% from the previous total of 2,180,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Sutro Biopharma's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Sutro Biopharma: Poseida Therapeutics, Inc. (9.73%), Monte Rosa Therapeutics, Inc. (6.01%), Adaptimmune Therapeutics plc (1.43%), Coherus BioSciences, Inc. (18.91%), Invivyd, Inc. (9.65%), SOPHiA GENETICS SA (0.11%), Agenus Inc. (16.80%), Zura Bio Limited (3.07%), Compass Therapeutics, Inc. (1.90%), Acumen Pharmaceuticals, Inc. (2.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Sutro Biopharma stock? Short selling STRO is an investing strategy that aims to generate trading profit from Sutro Biopharma as its price is falling. STRO shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sutro Biopharma? A short squeeze for Sutro Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of STRO, which in turn drives the price of the stock up even further. How often is Sutro Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including STRO, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: PSTX Short Squeeze GLUE Short Squeeze ADAP Short Squeeze CHRS Short Squeeze IVVD Short Squeeze SOPH Short Squeeze AGEN Short Squeeze ZURA Short Squeeze CMPX Short Squeeze ABOS Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:STRO) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBill Gates is all about this tiny $2 stockTimothy SykesElon’s New Device is About to Shock the WorldInvestorPlaceForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingBuy this small stock before coming AI Tidal WaveChaikin AnalyticsShocking $16T Elon Musk Crypto LeakCrypto 101 Media[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings